Comparison of Quality of Supraclavicular, Infraclavicular and Axillary Approach of Ultrasound-guided Brachial Plexus Block

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01442558

Enrollment

101

Registered

2011-09-28

Start date

2011-12-31

Completion date

2013-09-30

Last updated

2015-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

relief, Intra-operative

Brief summary

The aim of this study is to compare the quality of 3 methods of ultrasound-guided brachial plexus blocks for surgical anesthesia

Interventions

DRUGBupivacaine

Bupivacaine 5 mg/cc with adrenaline 5 mcg/cc will be injected with complete spread of the drug around nerves.

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* ASA I-III physical status * Surgery of distal arm, forearm or hand

Exclusion criteria

* Skin infection near block injection site * Allergy to local anesthetics * Peripheral neuropathy upper limb * INR of more than 1.4 * Thrombocytopenia * Opioid dependency * Chronic pain syndrome * Lack of orientation to person, place and time * Patient refusal

Design outcomes

Primary

Measure	Time frame	Description
Quality of 3 different approaches to brachial plexus block	Immediate	Whether or not there is need for additional analgesic drugs or need to switch to general anesthesia

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026